TOWN HALL – NIGMS Centers of Biomedical Research Excellence (COBRE) Phase 1
Join Lisa Cassis, Vice President for Research, the Proposal Development Office, and Phase 1 COBRE directors for a town hall to discuss an expanded opportunity for details on a new Phase 1 COBRE application to build research capacity in a focused area of biomedical research.
Thursday, May 4, 2023 from 12-1 pm
Information on UK’s current COBRE grants and their themes as well as pointers from current COBRE leaders will be shared.
Join from PC, Mac, Linux, or mobile device: https://uky.zoom.us/j/89951333673
Note: This opportunity is limited to one application per institution. Please see details of UK’s internal selection process for the opportunity detailed below at this portal:
For questions, contact PDO@uky.edu or diana.sama@uky.edu
Limited Submission – NIH – NIGMS Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) – PAR-22-250
Purpose: The National Institute of General Medical Sciences (NIGMS) invites applications for Centers of Biomedical Research Excellence (COBRE) from investigators at biomedical research institutions that award doctoral degrees in the health sciences. The COBRE program supports the establishment and development of innovative biomedical research centers at Institutional Development Award (IDeA)-eligible institutions through awards for three sequential five-year phases. The purpose of the COBRE Phase 1 award is to build capacity in an area of biomedical research through the establishment of a center of excellence that helps develop a critical mass of investigators who are able to compete effectively for independent research funding and improve infrastructure in the center's area of research. To achieve this goal, the COBRE award supports a Center that provides research support and mentoring to faculty investigators and funding for their recruitment. Enhancements to the institution's research infrastructure that facilitate the proposed research are also supported.
The Center's scientific goals must be aligned with the applicant institution's strategic priorities and cover a sufficiently broad scientific area to warrant the institution's sustained support. Applicant institutions should demonstrate their commitment to the COBRE program goals by investing in the recruitment and long-term support of the Center's investigators and the infrastructure required to carry out the scientific research. An established investigator with scientific expertise in the research area of the Center as well as mentoring and administrative experience is expected to lead the Center as the Program Director/Principal Investigator (PD/PI) of the award.
Eligibility: Institutions that, at the time of submission, (1) hold three or fewer active COBRE Phase 1 and/or Phase 2 awards, including those in no-cost extension. This recently announced expansion of the eligibility was issued by NIGMS in Notice NOT-GM-23-040. With this expansion, UK is now eligible to submit a COBRE Phase 1 application for the January 2024 deadline.
Funding Amount/ Project Period: up to $1.5 million in annual direct costs per year for five years
Link to Funding Opportunity Announcement
Institutional Limit: 1
Internal Competition: To participate in the university’s selection process, please upload the following, assembled into a single PDF file, to the Office of the Vice President for Research via this portal with a copy to your Associate Dean for Research by June 13, 2023:
- Names and departments/affiliations of the applicant and other key personnel or partners
- Title of program and/or funding opportunity announcement number
- Brief project description (2 pages maximum)
- Brief biographical sketch
A committee will be convened to review the material and make a recommendation.
For questions about the COBRE opportunity, email PDO@uky.edu. For questions or issues with submission through the portal, email the limited submission mailbox (limitedsubmissions@uky.edu), or call 257-2861.
Agency Deadline: January 30, 2024